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ABSTRACT 
The present review article aims at determining the various possible techniques available to enhance the quality, safety and efficacy of 
pharmaceutical formulations by exploring most suitable and practically applicable experimental designs and optimization techniques. As we know 
that pharmaceutical industries are constantly in search of novel ideas to improve quality by various optimization techniques, hence in present 
review article we shall discuss latest optimization techniques and experimental designs to achieve the best combination of product and process 
characteristics under the given set of conditions. Experimental designs and optimization techniques are the tools that are simultaneously and 
systematically used to identify various types of problems that may influence research, development and production of pharmaceutical formulations. 
These are organized an approach to determine the relationship between the factors affecting a process and the output of that process. The screening 
methods discussed here include factorial design, fractional factorial designs, full factorial design, mixture designs etc. Recently, different software has 
been used in implementing optimization techniques in pharmaceutical products to enhance product quality by using most suitable available facilities. 
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It is not always easy to get the solution of problems directly or 
instantly, so in those cases, we precede towards the various 
optimization methods in search of our answer. But as we know 
optimization is not as easy, as we have written, still it will lead to 
some conclusion [1]. The term optimization has been derived from 
optimize, that means to make as perfect, functional or effective as 
possible. In pharmacy, the word optimized was earlier used to 
suggest that a product has been improved to obtain the desired 
objectives of a development scientist, in pharmaceutical 
preparations or pharmaceutical processes; optimization is a 
technique of searching the best composition or experimental 
conditions. Optimization can be defined as the implementation of 
systemic approaches to obtain the best combination of product 
and/or processes characteristics under a given set of conditions or it 
can also be said as choosing the best element from some set of 
available alternatives [2].  
The main aim of designing quality formulations is achieved by 
implementing various Optimization techniques (OT) like 
Experimental Design (ED), the terms Formulation by Design (FBD) 
and Quality by Design (QBD) indicates that quality in the product can 
be developed by using various techniques of ED [3-5]. Earlier, any new 
pharmaceutical formulation was designed by studying the influence of 
composition and process variables on dosage form characteristics, 
changing one single or separate factor at a time while keeping others 
constant, this technique was also called as changing one variable at a 
time or one factor at a time. By this technique, problem may be solved 
but it does not guarantee the true optimum concentration or process 
and the product obtained may be suboptimal. Some of the limitations 
of traditional methods are: unpredictable, uneconomical, time-
consuming, energy utilizing, unsuitable to plug errors, yielding only 
workable solutions, non-suitable to reveal interactions, energy 
utilizing etc. [2] So, in order to overcome these errors a novel 
approach was followed, which is optimization technique, that involves 
systematic ED [6]. The following steps represent the latest 
optimization techniques for drug delivery system in pharmaceuticals:  
 Defining objectives of the study and planning the experiment. 
 Screening of factors and factors influencing studies. 
 Response surface methodology using experimental designs. 
 Formulation and evaluation of drug delivery systems as per 
experimental design. 
 Computer-aided modelling and search for an optimum. 
 Validation of design of experiments methodology. 
 Scale-up and implementation in pharmaceutical production. 
The objectives of optimization techniques are involved to maintain 
the quality, economy and safety of public and industry. Whereas the 
significance of optimizing a pharmaceutical product involved the 
discovery of important variables involved, cheaper and efficient way 
of formulating the product and improving the consistency and 
usefulness of quality specification in the formulation [7]. OT and ED 
are tools that are used specifically to examine various problems that 
are encountered during research, development and production. It is 
obvious that if experiments are performed randomly the result 
obtained will also be random. Therefore, it is essential to plan the 
experiments in such a way that the relevant information will be 
obtained.  
Important terminology used in optimization  
Variables 
These are the measurements or values that are characteristics of the 
data. There are two types of variables, dependent and independent 
variables. Formulation and process variables are directly controlled 
by the formulator, these include ingredients. Dependent or 
secondary variables are the responses of in-progress material or the 
resulting drug delivery system; it is the result of independent 
variables. 
Factor 
The factor is an assigned variable like concentration, temperature, 
lubricating agent, drug-polymer ratio, polymer-polymer ratio etc. A 
factor can be qualitative or quantitative. A quantitative factor has a 
numerical value to it e. g., concentration (1%, 2% so on), a drug to 
polymer ratio (1:1, 1:2 etc). Qualitative factors are the factors, which 
are no numerical, e. g., Polymer grades, humidity condition, type of 
equipment etc, these are discrete in nature. The factor is Assigned 
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and Independent variable that affects the product or output of the 
process. It is an assigned quantitative and qualitatively as follows:  
Quantitative: A numerical factor is assigned to it. Example: 
Concentration-1%, 2%, 3% etc. 
Qualitative: These are non-numerical. Example-Polymer grade, 
humidity condition etc. 
Level: The levels of a factor are values or designation assigned to the 
factor, e. g., concentration (factor) 1% will be one level, while 2% 
will be another level. Two different plasticizers are levels of grade 
factor. Usually, levels are indicated as low, middle or high level. 
Normally for ease of calculation, the numeric and discrete levels are 
converted to-1 (low level) and+1 (high level). The general formula 
for this conversion is X — the average of the two levels Level =Half 
the difference of levels Where ‘X’ is the numeric value. 
Response: Response is mostly interpreted as the outcome of an 
experiment. It is the effect, which we are going to evaluate i.e., 
disintegration time, duration of buoyancy, thickness, etc. It is an 
outcome of the experiment. 
Response surface: Response surface representing the relationship 
between the independent variables X1 and X2 and the dependent 
variable Y. 
Run or trials: Experiments conducted according to the selected 
experimental designs. 
Screening: To sort out something from. 
Contour Plot: Geometric illustration of a response obtained by 
plotting one independent variable against another, while holding the 
magnitude of response and other variables as constant. 
Interaction: It is also similar to the term effect, which gives the 
overall effect of two or more variables (factors) of a response. For 
example, the combined effect of lubricant (factor) and glidant 
(factor) on hardness (response) of a tablet. From the optimization, 
we can draw a conclusion about Effect of a factor on a response 
i.e., change in dissolution rate as the drug to polymer ratio 
changes. The relationship between various factors and response, 
those are a quantitative change of a response as we change the 
factors and its levels. The contribution effect i.e., whether two 
factors are contributing additively or antagonistically for a 
response, e. g., any relationship between the concentration of 
lubricant and glidant on the hardness of the tablet or flow 
property of the granules. It gives the overall effect of two or more 
variables means lack of summation of factor effects.  
Effect: The effect of a factor is the change in response caused by 
varying the levels of the factor. This describes the relationship 
between factors and levels. 
Multiple Linear Regression Analysis: The technique which expresses 
mathematically in form of the quadratic equation the linear 
relationship between a various independent variable and the 
dependent variable (Response). 
Orthogonality: When the effect is due to the main factor of interest 
and no interaction. 
Confounding: Lack of Orthogonality is termed as confounding or 
aliasing. 
Resolution: Measurement of the degree of confounding. 
Effect: The effect of a factor is the change in response caused by 
varying the levels of the factor. This describes the relationship 
between factors and levels [8-10]. 
Optimization parameters 
The optimization parameters are broadly divided into two types: 
Problem type and Variables [11]. 
Problem type 
The problem type of parameters again grouped into:  
• Constrained type: Constrained types are, restrictions placed on 
the system by means of physical limitations or perhaps by simply 
practical based. This can best explained by taking hardness of tablet 
and its disintegrating time in less than 15 min. 
• Unconstrained type: In unconstrained type, there are no restrictions 
placed on the system by means of physical limitations or perhaps by 
simply practical based. But in pharmaceuticals, there is always a 
limitation of a means of a physical limitation or perhaps by simply 
practically the formulator wishes to place or must place on a system.  
Variables 
There are several variables in pharmaceutical formulation and 
processing but generally, variables can be classified into:  
• Independent variables: These are directly under the control of 
formulator. Example: mixing time. 
• Dependent variables: these are not directly under the control of 
formulator. Example: Homogeneity of mixed granules. 
Experimental designs (ED) 
It is an approach where the process variables are first screened to 
determine which are important to the outcome (excipients type, 
percentage, disintegration time (DT) etc [12-14]. The second step is 
the ‘optimization’, when the best settings for the important variables 
are determined. It involves the use of ‘mixture designs’ for changing 
mixture composition and exploring how such changes will affect the 
properties of the mixture. Experimental design is a statistical design 
that prescribes or advises a set of combination of variables. The 
number and layout of these design points within the experimental 
region depends on the number of effects that must be estimated. 
Depending on the number of factors, their levels, possible 
interactions and order of the model, various experimental designs 
are chosen. Each experiment can be represented as a point within 
the experimental domain. The point being defined by its coordinate 
(the value is given to variables) in the space [8]. It is an organized 
method used to determine the relationship between the factors (Xs) 
affecting a process and the output of that process (Ys). Statistical 
Experimental Design (ED) refers to the process of planning the 
experiment in such a way that suitable data can be collected and 
analyzed statistically, resulting in a valid and objective conclusion. 
This approach is used to draw meaningful conclusions from 
experimental data [15-22]. 
Advantages of ED 
 Better innovation due to the ability to improve processes. 
 Less batch failures. 
 Greater regulator confidence of robust products. 
 More efficient technology transfer to manufacturing. 
 Replications of results are obtained. 
Uses of ED 
It is used to determine the causes of variation in the response, to 
determine the conditions under which the optimal (maximum or 
minimum) response is achieved, to compare responses at different 
levels of controlled variables and to develop a model for predicting 
response. 
Key steps for experimental design 
To obtain good results from ED the following steps are followed:  
 Set objective. 
 Select process variables. 
 Select an experimental design. 
 Execute the design. 
 Check that the data are consistent with the experimental 
assumptions. 
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 Analyze and interpret the results. 
Selection of ED 
The choice of an experimental design depends on the objectives of 
the experiments and the number of factors to be investigated. 
Objective of ED 
 Comparative analysis. 
 Optimal fitting of regression model estimation. 
 Response surface method determination.  
 Optimizing response when factors are proportions of a mixture.  
 Screening.  
Types of ED 
There are various types of ED available out of which method we 
have to use depends upon the resources we have and the 
parameters we want to estimate.  
Factorial designs 
Factorial designs (FD) were initially used in the 19th century by John 
Bennet Lawes and Joseph Henry Gilbert. A factorial design allows the 
effect of several factors and even interactions between them to be 
determined with the same number of trials as are necessary to 
determine any one of the effects by itself with the same degree. Theses 
designs are very frequently used response surface designs. A factorial 
experiment is one in which all levels of a given factor are combined 
with all levels of every other factor in the experiment. These are 
generally based upon first-degree mathematical models. First, 
whenever we are interested in examining treatment variations, 
factorial designs should be strong candidates as the designs of choice. 
Second, factorial designs are efficient. Instead of conducting a series of 
independent studies we are effectively able to combine these studies 
into one. Finally, these are the only effective way to examine 
interaction effects. Latest application of FD includes optimization of 
ibuprofen fast dissolving tablets [23-25]. 
Fractional factorial design 
Fractional factorial design is generally used for screening of factor. 
This design has low resolution due to less number of run. Although 
these designs are economical in terms of number of experiments, the 
ability to distinguish some of the factor effects is partly sacrificed by 
reduction in the number of experiments. 
Full factorial design (FFD) 
It is an experimental design, which uses dimensional factor space at 
the corner of the design space. Factorial designs (FD) are used in 
experiments where the effects of different factors or used in 
experiments where the effects of different factors or conditions on 
choice for simultaneous determination of the effect of several factors 
and their interactions. The simplest factorial design FD is the 2 
factorial designs, where two factors are considered each at two 
levels, leads to four experiments, which are situated in 2-
dimensional factor space at the corners of a rectangle. If there are 3 
factors, each at two levels, eight experiments are necessary which 
are situated at the corners of an orthogonal cube on a 3-dimensional 
space. The number of experiments is given by 2, where ‘n’ is the 
number of factors. If the number of factors and levels are large, then 
the number of experiments needed to complete a factorial design is 
large. To reduce the number of experiments, fractional factorial 
design can be used (i.e., ½ or ¼ of the original number of 
experiments with full factorial design). The fitting of an empirical 
polynomial equation to the experimental result facilitates the 
optimization procedure. The general polynomial equation is as 
follows: Y = B0+B1X1+B2 X2+B3 X3++B12 X1X2+B13X1X3+ 
B23X2X3 —-Where Y is the response, X1, X2, X3 are the levels 
(concentration) of the 1, 2, 3 factors and B1, B2, B3, B12, B13, B23, 
are the polynomial coefficients, B 0 is the intercept (which 
represents the response when the level of all factors is low). 
Olmesartan and carbamazepine formulations had been developed by 
using full factorial design [7, 26, 27].  
Plackett-burman designs (Hadamard designs) 
Plackett-Burman designs (PBD) are special two-level FFDs used 
generally for the screening of factors. This design is generally used 
when we want to screen a high number of factors if we want to 
study the effect of 7 factors then we have to show four dummy 
factors. The interpretations of results in FFD, PBD and taguchi 
design (TD) are drawn with the help of Pareto chart and half normal 
plot. These designs prove to be effective screening designs when 
only main effects are of interest. They economically detect large 
main effects, assuming all interactions negligible when compared 
with few main effects. These designs are also called as saturated 
designs as it investigates n*4 experiments i.e. 8, 12, 16, 20, etc that is 
suitable for studying up to 7, 11, 15, 19, etc factors respectively. 
Central composite design (Box-Wilson design) 
This design was developed by Box and Wilson. A better design that 
encompasses the advantages of factorial design or fractional factorial 
design or the star design, is the central composite design (CCD). It is 
composed of +2k Factorial design or Fractional factorial design. For 
nonlinear responses requiring second-order models, central composite 
designs CCDs are the most frequently employed. A two-factor CCD is 
identical to a 32 FD with the rectangular experimental domain at α =±1, 
On the other hand, the experimental domain is spherical in shape for α = 
√2 = 1.414. The CCD is quite popular in response surface optimization 
during pharmaceutical product development. Practical application of 
CCD is the formulation of glipizide [28]. 
Box-behnken designs (BBD) 
A specially made design, BBD requires only three levels for each 
facto-l, 0 and+1. It employing 15 experiments run with three factors 
at three levels. It is economical then CCD because t requires less 
number of Trial. Implementation of BBD in tenofovir preparation 
and fabrication of nateglinide nanoparticles [29, 30]. 
Taguchi design (TD) 
Taguchi refers to experimental design as "off-line quality control" 
because it is a method of ensuring good performance in the 
development of products or processes." It is also used for screening 
of factors and it provides 8 experimental runs for 7 factors. Example 
of TD is the preparation of glicalazide [31].  
Mixture design (MD) 
These designs represent the quantity of each substance present but on 
their proportions. The sum total of the proportions of all the excipients 
is unity, and none of the fractions can be negative. Therefore, the levels 
of different components can be varied with the restriction that the 
sum total should not exceed one. In pharmaceutical formulations with 
multiple excipients, the characteristics of the finished product usually 
do not depend on the quantity of each substance but depend on their 
proportions. Here, the sum total of the proportions of all excipients is 
unity and none of the fractions can be negative.  
Therefore, the levels of the various components can be varied with the 
restriction that the sum total should not exceed one. In a two-
component mixture, only 1 factor level can be independently varied, 
while in a three-component mixture, only two-factor levels can be 
independently varied. The remaining factor level is chosen to complete 
the sum to one. Hence, they have often been described as ED for the 
formulation optimization. For process optimization, designs like FD 
and CCD are preferred. There are several types of mixture designs, the 
most popular being the simplex designs. A simplex is the simplest 
possible n-sided fig. in a (n-1) dimensional space. It is represented as a 
straight line for two components, as a 2-D triangle for three 
components, as a 3-D tetrahedron for four components and so on. The 
design points are uniformly distributed over the factor space and form 
the lattice. The practical use of Mixture design (MD) can be observed 
in solubilization study of celecoxib [32].  
Screening designs (SD) 
These are used for detecting the important factor and their level 
which affect the quality of formulation, these designs generally 
support only the linear responses. 
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Response surface designs (RSD) 
These are used when we required exact image of response, estimating 
interaction and even quadratic effects. RSD generally support 
nonlinear and quadratic response and capable of detecting curvatures. 
Star design 
The star design is simply a 22 factorial design rotated over 45 ° 
angle in the space. A center point is usually added, which may be 
replicated to estimate experimental error, so there will be three 
levels for each factor where the quadratic effect can be measured, 
but the interaction effect cannot be measured as in case of the FFD. 
In star design, 2k Factorial designs are rotated over 45 ° in (k-i) 
direction in k-dimensional space with a replicated center point. K is 
the number of factors in the design. This results in 2k+R 
experiments, where R is the replicate of the center point. 
Box design (BD) 
In central composite design, each factor has five levels. If the number 
of factors increases, the number of experiments may become too high. 
BD is used when three or more factors are an economical alternative 
in which each factor is given three levels. The design is called an 
orthogonal balanced incomplete block design. It can be split into a set 
of incomplete blocks, which means that every effect is not estimated in 
every block, but every factor effect is measured as an equal number of 
times with a balanced partition over the different blocks. 
Doehiert hexagon or uniform shell design (USD) 
Doehiert proposed uniform shell designs (USD), starting with an 
equilateral triangle, mirrored in one side to a hexagon. The hexagon 
is expandable in 2-dimensional space by mirroring the center point 
in the outward sides. The equally spaced design points are uniformly 
distributed in concentric circles. It is also expandable in 3-dimension 
to concentric spherical shells. Due to the uniform distribution, 
models based on this design provide, a good basis for interpolation. 
A disadvantage may be that the number of levels is not same for all 
factors. The design may be started with one side of the hexagon 
parallel to the most important axis. 
Simplex lattice design (SLD) 
These designs are used to explore the interior and the boundaries of 
the simplex. The number of factors determines its dimensions. The 
pattern of design points in the factor space and their number depend 
on the degree (the term of the highest order) of the model that is 
postulated. The points are distributed orderly over the factor space, 
forming a lattice. The factors can be controlled accurately and 
precisely. The coefficients of model equation can be calculated easily. 
Extreme vertices design (EVD) 
It often occurs in formulation studies that the whole factor space is not 
accessible for experiment or that some areas are expected not to give 
useful responses. In an Extreme Vertices design, observations are 
made at the corners of the bounded design space, at the middle of the 
edges and at the center of the design space. These can be used for the 
mixture composition as well as in combination with factorial designs. 
D-optimal design (DOD) 
This design explains that these designs maximize the information in 
the selected set of experimental runs with respect to a stated model. 
The D-Optimal design (DOD) maximizes the determinant, of which is 
an overall measure of the information. Geometrically, this 
corresponds to maximizing the volume in a dimensional space. 
There is a linear constraint on the factor settings, reducing the 
experimental region to an irregular polyhedron. There are no 
classical designs that can well investigate an irregular region, then 
DOD is then the preferred choice as it makes efficient use of the 
entire experimental space. There are formulation factors, with lower 
and upper bounds, and possibly additional constraints, making the 
region an irregular polyhedron. There are qualitative factors, with 
more than two levels and there is no mixed level design available, or 
the mixed level design suggests too many runs to be acceptable. The 
objective is Response Surface Matter (RSM) and there are qualitative 
factors. The number of experimental runs affordable is smaller than 
the number of runs of any available classical design. 
Sequential optimization design (SOD) 
Despite numerous merits of simultaneous approaches, there are 
situations where there is hardly any prior knowledge about the 
effects of variables. Such situations call for the application of the 
sequential methods. In sequential approach, optimization is 
attempted in a step-wise fashion. Experimentation is started at an 
arbitrary point in the experimental domain and responses are 
evaluated. An important aspect of sequential designs is to know 
when the goal has been accomplished. 
Interpretation of experimental design data 
Assume that we have a final model that has passed all the relevant 
tests that includes visual and quantitative tests, then we and are ready 
to make conclusion and decisions. These should be the response to the 
outputs dictated by the original experimental goals [33-37]. 
Optimization of important factors 
Model development 
A model is an expression defining the quantitative dependence of a 
response variable on the independent variables. Usually, it is a set of 
polynomials of a given order or degree. From this polynomial 
equation, we calculate the coefficient with the help of principal of 
MLRA (Multiple Linear Regression Analysis). By the help of 
software, we can also study here the effect of excipients, their 
interaction study, 3D Response plot, Contour Plot etc. In screening 
design with the help of half normal plot and Pareto chart, we can 
find out easily the main factor and their level. From the models thus 
selected, optimization of one response or the simultaneous 
optimization of multiple responses needs to be optimized 
graphically, numerically and by using Brute force search technology. 
 Graphical Optimization (GO): It is also known as response 
surface analysis (RSA) deals with selecting the best possible 
formulation out of a feasible factor space region. To do this, the 
desirable limits of response variables are set, and the factor levels 
are screened accordingly by the help of overlay plot [38]. 
 Brute-force search (Feasibility and Grid search): Brute-force 
search technique is the simple and exhaustive search optimization 
technique. It checks each and every single point in the function space. 
Herein, the formulations that can be prepared by almost every possible 
combination of independent factors and screened for their response 
variables. Subsequently, the acceptable limits are set for these responses, 
and an exhaustive search is again conducted by further narrowing down 
the feasible region. The optimized formulation is searched from the final 
feasible space that is called as grid search, which fulfils the maximum 
criteria set during experimentation. 
 Numerical Optimization: It deals with selecting the best 
possible formulation out of a suitable factor. To do this, the desirable 
limits of response variables are set, and the factor levels are 
displayed by the software. Other techniques used for optimizing 
multiple responses are canonical analysis, ANNs and mathematical 
optimization [39-41]. 
Validation of model 
The predicted optimal formulation or the checkpoint is prepared as 
per optimum factor level and the responses evaluated. On 
comparison of results of observed and predicted response 
conclusion will be drawn for model validation. 
The following points should be considered before selecting any 
software for Experimental Designs and Optimization techniques:  
 A simple graphic user interface (GUI) that's intuitive and easy-to-use. 
 A well-written manual with tutorials to get you off to a quick start. 
 A wide selection of designs for screening and optimizing 
processes or product formulations. 
 A spreadsheet flexible enough for data entry as well as dealing 
with missing data and changed factor levels. 
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 Graphic tools displaying the rotatable 3D response surfaces, 2D 
contour plots interaction plots and the plots revealing model diagnostics. 
 Software that randomizes the order of experimental runs. 
Randomization is crucial because it ensures that "noisy" factors will 
spread randomly across all control factors. 
 Design evaluation tools that will reveal aliases and other 
potential pitfalls. 
 After-sales technical support, online help and training offered by 
manufacturing vendors. 
 
Table 1: Various software used in optimization techniques 
Software Features 
Design Expert Optimizing pharmaceutical formulations and processes; allows screening and study of influential variables for FD, FFD, BBD, CCD, 
PBD and mixture designs; provides 3D plots that can be rotated to visualize the response surfaces and 2D contour maps; 
numerical and graphical optimization 
DE PRO XL and 
DE KISS 
MS-Excel compatible DE software for automated data analysis using Taguchi, FD, FFD and PBD. The relatively inexpensive 
software, DoE KISS is, however, applicable only to the single response variable. 
Mini Tab Powerful DoE software for automated data analysis, graphic and help features, MS-Excel compatibility, includes almost all designs of RSM 
MATREX Excel compatible optimization software with facilities for various experimental designs and Taguchi design. 
OPTIMA Generates the experimental design, fits a mathematical equation to the data and graphically depicts response surfaces 
OMEGA Only for mixture designs; only program that supports multi-criterion decision making by Pareto-optimality, up to six objectives 
and has various statistical functions 
FACTOP Aids in the optimization of formulation using various FDs, and other designs through development of polynomials and grid 
search; includes computer-aided-education module for optimization 
GRG2 Mathematical optimization program to search for the maximum or minimum of a function with or without constraints [42]. 
 
CONCLUSION 
After having a detailed study on the effect of OT and experimental 
designs ED in pharmaceutical formulations, we can conclude that 
these parameters are highly influential in enhancing the quality, safety 
and efficacy of pharmaceutical products. Optimization techniques are 
also helpfull in reducing the cost of the product by minimizing the 
number of experimental trials during formulation development. The 
optimized experimental designs are also effective in analyzing 
accurate quality assurances to regulatory authorities, regarding 
enhanced product quality. From the above study, it can be concluded 
that FD and CCD are most preferred designs for optimization. This 
field of study that is optimization of pharmaceutical formulations by 
various experimental designs ED is a recent trend of the investigation. 
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